Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Am Acad Child Adolesc Psychiatry ; 58(12): 1218-1222.e1, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31374252

RESUMO

There has been growing concern about the safety and efficacy of psychotropic prescribing practices for children enrolled in Medicaid and in foster care.1 In response, accreditation organizations and policymakers have developed standards for optimal use of psychotropic medications among children.2 In addition, federal legislation has prompted states to implement monitoring programs to address quality and safety issues among vulnerable pediatric subpopulations.3,4 Here, we report findings from an evaluation of Indiana's program for foster youth, which used outlier case review followed by peer-to-peer consultation between prescribing physicians and child and adolescent psychiatrists. We observed clinically and statistically significant reductions in polypharmacy, off-label prescribing, inpatient hospitalizations, health care costs, and related outcomes among youths randomized to an immediate intervention group compared to no improvements in a waitlist control group.


Assuntos
Criança Acolhida/estatística & dados numéricos , Transtornos Mentais/terapia , Padrões de Prática Médica/estatística & dados numéricos , Psicotrópicos/uso terapêutico , Encaminhamento e Consulta/estatística & dados numéricos , Adolescente , Antidepressivos/uso terapêutico , Antipsicóticos/uso terapêutico , Criança , Pré-Escolar , Humanos , Indiana , Medicaid/estatística & dados numéricos , Polimedicação , Medicamentos sob Prescrição/uso terapêutico , Estados Unidos
2.
Semin Pediatr Neurol ; 25: 123-135, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29735110

RESUMO

Pediatric movement disorders may present with psychiatric symptoms at many points during the course of the disease. For the relatively common pediatric movement disorder, Tourette syndrome, psychiatric comorbidities are well-described and treatment is well-studied. Managing these comorbidities may be more effective than improving the movements themselves. For more uncommon movement disorders, such as juvenile-onset Huntington disease, treatment of psychiatric comorbidities is not well-characterized, and best-practice recommendations are not available. For the least common movement disorders, such as childhood neurodegeneration with brain iron accumulation, psychiatric features may be nonspecific so that underlying diagnosis may be apparent only after recognition of other symptoms. However, psychiatric medication, psychotherapy, and psychosocial support for these disorders may prove helpful to many children and adolescents.


Assuntos
Transtornos Mentais/complicações , Transtornos dos Movimentos/complicações , Criança , Comorbidade , Humanos , Transtornos Mentais/diagnóstico , Transtornos Mentais/epidemiologia , Transtornos Mentais/terapia , Transtornos dos Movimentos/diagnóstico , Transtornos dos Movimentos/psicologia , Transtornos dos Movimentos/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...